Vigabatrin-Induced Encephalopathy;Fidaxomicin Hypersensitivity Reactions;Vemurafenib-Induced DRESS;Severe Alkalosis and Hypokalemia with Stanozolol Misuse;Isotretinoin-Associated Lip Abscess;Eltrombopag-Associated Hyperpigmentation

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MEDWATCH program (800-FDA-1088). If you have reported an interesting, preventable ADR to MEDWATCH, please consider sharing the account with our readers.